Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Lansoprazole to Treat Children With Asthma

ClinicalTrials.gov ID: NCT00442013

Public ClinicalTrials.gov record NCT00442013. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 10:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III: The Study of Acid Reflux in Children With Asthma

Study identification

NCT ID
NCT00442013
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Johns Hopkins University
Other
Enrollment
306 participants

Conditions and interventions

Conditions

Interventions

  • Lansoprazole Drug
  • Matching placebo Drug

Drug

Eligibility (public fields only)

Age range
6 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2007
Primary completion
Mar 31, 2011
Completion
Jul 31, 2011
Last update posted
Dec 5, 2012

2007 – 2011

United States locations

U.S. sites
20
U.S. states
15
U.S. cities
20
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233
University of California San Diego San Diego California 92103
National Jewish Medical and Research Center Denver Colorado 80206
Nemours Children's Clinic Jacksonville Florida 32207
University of Miami School of Medicine Miami Florida 33613
University of South Florida College of Medicine Tampa Florida 33613
Emory University School of Medicine Atlanta Georgia 30322
Northwestern Memorial Hospital Chicago Illinois 60611
Indiana University Indianapolis Indiana 46202
University of Minnesota Minneapolis Minnesota 55455
University of Missouri, Kansas City School of Medicine Kansas City Missouri 64108
Washington University School of Medicine St Louis Missouri 63110
North Shore-Long Island Jewish Health System New Hyde Park New York 11040
New York University School of Medicine New York New York 10016
New York Medical College Valhalla New York 10595
Duke University School of Medicine Durham North Carolina 27710
Davis Heart and Lung Research Institute Columbus Ohio 43210
Penn Presbyterain Medical Center/Penn Lung Center Philadelphia Pennsylvania 19104
Baylor College of Medicine Houston Texas 77030
Vermont Lung Center at The University of Vermont Burlington Vermont 05405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00442013, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 5, 2012 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00442013 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →